Position in GSK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,893,357
-$68,150 QoQ
Shares Held
36,119
+1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#272
of 1,032 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Royal Fund Management, LLC holds $53,687,214 across 9 Drug Manufacturers - General names. GSK ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
50,828 | $12,790,357 | |
| 2 | JNJ |
Johnson & Johnson
|
37,731 | $9,582,542 | |
| 3 | MRK |
Merck & Co., Inc.
|
71,225 | $9,152,412 | |
| 4 | AMGN |
Amgen Inc
|
22,196 | $8,037,615 | |
| 5 | LLY |
ELI LILLY & Co
|
5,141 | $6,166,270 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
67,139 | $3,868,549 | |
| 7 | GSK |
GSK plc
This page
|
36,119 | $1,893,357 | |
| 8 | PFE |
Pfizer Inc
|
77,701 | $1,871,040 |
All Filings in GSK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,893,357 | 36,119 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,961,507 | 35,541 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $1,706,248 | 34,793 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,155,350 | 26,769 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,124,044 | 29,272 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $998,329 | 25,770 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $812,525 | 24,025 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,735,601 | 42,456 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $873,873 | 22,698 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,064,504 | 24,831 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $903,856 | 24,389 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $845,495 | 23,324 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $791,920 | 22,220 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $847,124 | 23,809 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $719,350 | 20,471 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $537,686 | 18,270 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $645,707 | 15,124 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $381,863 | 8,938 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $319,684 | 7,391 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $239,586 | 6,393 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $222,420 | 5,695 | Shares | Sole | 2021-07-26 | |
| 2020-09-30 | $198,688 | 5,382 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $218,117 | 5,452 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $294,661 | 7,929 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||